INS and Hypoglycemia: There have been multiple case reports describing adult patients with type 2 diabetes mellitus who experienced decreasing insulin requirements, improving glycated hemoglobin (HbA1c) levels, and/or hypoglycemia after receiving dasatinib [2‐4].